FROM ASPIRIN TO BIOLOGICS - THERAPEUTIC IMPLICATIONS FOR RHEUMATOID-ARTHRITIS

被引:0
作者
WRIGHT, V
机构
关键词
RHEUMATOID ARTHRITIS; ASPIRIN; PHENYLBUTAZONE; NSAID; DMARD; METHOTREXATE; CYCLOSPORINE-A; 2ND LINE THERAPY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As effective antiinflammatory agents have been added to our armamentarium, 2 major treatment strategies for the treatment of rheumatoid arthritis have developed. The traditional pyramid strategy is based on initial, conservative measures, followed by more aggressive therapy as the disease progresses. The step-down bridge approach is an alternative, more aggressive strategy that favors earlier use of more potent agents. The longterm effects of modifying antirheumatic drugs (DMARD) and combination second line therapy on disease progression remain unclear. Advances in the development of more specific DMARD and in human recombinant proteins offer promising future therapies.
引用
收藏
页码:95 / 97
页数:3
相关论文
共 8 条
  • [1] Chamberlain M A, 1976, Rheumatol Rehabil, V15, P17, DOI 10.1093/rheumatology/15.1.17
  • [2] FRIES JF, 1990, J RHEUMATOL, V17, P12
  • [3] 4 NEW ANTI-INFLAMMATORY DRUGS - RESPONSES AND VARIATIONS
    HUSKISSON, EC
    WOOLF, DL
    BALME, HW
    SCOTT, J
    FRANKLYN, S
    [J]. BRITISH MEDICAL JOURNAL, 1976, 1 (6017) : 1048 - 1049
  • [4] EFFECT OF GOLD TREATMENT ON PROGRESSION OF EROSIONS IN RA PATIENTS
    LUUKKAINEN, R
    ISOMAKI, H
    KAJANDER, A
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1977, 6 (02) : 123 - 127
  • [5] MARTIN M, 1982, ANN RHEUM DIS, V41, P631
  • [6] SCOTT DL, 1987, LANCET, V1, P1108
  • [7] WOLFE F, 1991, J RHEUMATOL, V18, P672
  • [8] WRIGHT V, 1991, Journal of Drug Development, V3, P189